At 14.8% of CAGR, Genome Editing Market Anticipated to Grow $10.1 Billion by 2027 | Thermo Fisher Scientific Inc., Merck KGaA, GenScript, etc.

The global Genome Editing Market is expected to reach USD 10.1 billion by 2026, according to a new report by Reports and Data. Genome editing refers to a genetic engineering method used for insertion, deletion, or modification in the genome of any organism. Genome editing has come up as promising tool with wide scale application of established genetic engineering technologies such as TALEN and introduction of new methods such as CRISPR technology.

The Genome Editing Market Report is updated with the current economic landscape after the COVID-19 pandemic. The outbreak has brought about some significant changes in the global economy, especially in production and consumption. The report studies the business landscape and gives present and future assessment of the aftereffects of the pandemic.

Ask for Sample Report at: https://www.reportsanddata.com/sample-enquiry-form/1052

The market is driven by the increasing incidence of genetic diseases, favorable funding scenario for research & development in the field of genetic engineering, technological advancements in genetic engineering such as developments in CRISPR technology, increasing focus of food industry on genetically modified organisms, and rising awareness about efficacy as well applications of genetic engineering methods. For instance, globally over 175 million hectares of land is used for GM crops production. However, stringent regulatory scenario and ethical concerns for gene editing research and applications and concerns among end users regarding use of gene alteration therapies are likely to hinder the market growth during the forecast period.

Some leading players profiled in the report are: Thermo Fisher Scientific Inc., Merck KGaA, GenScript, Horizon Discovery Group Plc, Integrated DNA Technologies, Inc, Lonza, New England Biolabs and Sangamo Therapeutics, Inc.

For the purpose of this report, Reports and Data has segmented the Genetic Editing market on the basis of type, application, end user and region:

Type Outlook (Revenue, USD Million, 2020 - 2027)
• Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
• Transcription Activator-Like Effector Nucleases (TALEN)
• Zinc Finger Nucleases (ZFN)
• Others

Application Outlook (Revenue, USD Million, 2020 - 2027)
• Animal Genetic Engineering
• Plant Genetic Engineering
• Cell Line Engineering

End User Outlook (Revenue, USD Million, 2020 - 2027)
• Pharma-Biotech Companies
• Academic Institutes & Research Center
• Agrigenomic Companies
• Contract Research Organizations

Regional Outlook (Revenue, USD Million, 2020 - 2027)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Further key findings from the report suggest:-

CRISPR market is rising at a high growth rate of 30.9 percent in Asia Pacific followed by North America and Europe. Rising application of genetic engineering for therapeutics will drive the demand for the market during forecast period across all regions.

The valuation for TALEN market was USD 1.79 billion in 2020 and is expected to grow to USD 2.01 billion by 2027. Benefits associated with TALEN high degrees of precision and control, is the key factor supporting the wide-scale adoption of the technology and consequently contributing to the market growth.

Asia Pacific is expected to witness a CAGR of 15.8 percent in the forecast period. Emerging markets such China and Japan are likely to witness high growth

Regional regulatory approval is another key regulatory factor for adoption and growth of genetic editing in the region.

To Ask About Report Sample, Availability or Customization, Click Here: https://www.reportsanddata.com/request-customization-form/1052

The research offers an evaluation of leading players operating in the Global Genome Editing Market. It also provides a summary and sheds light on the current competitive scenario in the market. This research report gives an exhaustive study to the investors and stakeholders engaged in the Genome Editing market. Moreover, the report offers key information about buyers, suppliers, and manufacturers in the market. It also includes a comprehensive analysis of production, consumption, market share, and growth rate of each application assessed in the report.

This study highlights the current scenario of the Global Genome Editing Market, market forecast, growth opportunities, key market segments, and emerging players. The study aims to analyze the Genome Editing growth in the key regions. In order to offer valuable insights relating to the key factors of the market, the report assesses the market segments included in the study extensively. Emerging market players are attempting to establish their presence in the market. Strategic alliances will potentially change the existing industry dynamics.

Table of contents:

Chapter 1 analyzes the Genome Editing Introduction, product offerings, and scope, complete market overview, growth opportunities, market risks, driving forces, and others.

Chapter 2 presents a detailed study of the key manufacturers of Genome Editing, along with sales, revenue, and the price of Genome Editing.

Chapter 3 includes the competitive scenario among the major manufacturers and vendors.

Chapter 4 studies the global Genome Editing market by regions, clubbed with sales, revenue, and market share of Genome Editing, for each region from 2016 to 2026.

Chapters 5, 6, 7, 8 and 9, study the market by region, by type, by application, and by manufacturers, with the sales, revenue, and market share included based on key countries in these regions.

Browse the Full Report @ https://www.reportsanddata.com/report-detail/genome-editing-market

The Genome Editing Market report is updated with the latest economic scenario with the value, drivers, constraints, demand and supply ratio, production capacity, import/export status, growth rate, and others. Additionally, the report also undertakes SWOT Analysis and Porter’s Five Forces Analysis to assess the leading companies.

Thank you for reading our report. For further details or to inquire about customization, please let us know and we will offer you the report as per your needs.

Contact Us:

John Watson
Head of Business Development
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Us:

We are a boutique market intelligence and strategic consulting firm dedicated to having a meaningful impact on businesses across the globe. Our stellar estimation and forecasting models have earned recognition across majority of the business forum.

This release was published on openPR.